A patient with multiple sclerosis is to begin treatment with interferon beta. The patient comes to the clinic to have pretreatment laboratory tests. Which statement by the patient indicates a need for further teaching about these tests?
a. After the first year of treatment, I will need once yearly blood work.
b. I will need to have lab tests done every 3 months for the first year.
c. If my liver function tests are abnormal, I will need to stop using this drug.
d. These lab tests will measure liver and bone marrow function.
Question 2
A patient administers interferon beta-1a SQ (Rebif) 22 mcg/0.5 mL three times each week.
The patient calls the nurse to report unrelieved itching and erythema at the injection site, despite the use of topical hydrocortisone for several weeks. What will the nurse tell this patient to do?
a. Apply ice to the injection site before and after the injection.
b. Ask the provider to reduce the dose of interferon beta to 8.8 mcg/0.2 mL.
c. Discuss using a prescription-strength hydrocortisone product with the provider.
d. Take oral diphenhydramine (Benadryl).
(A) Scratch test; patient is exposed to allergens through a light scratch on the skin; (B) Positive
Patient with exophthalmos.
Caring for a patient on isolation precautions cont'd
Pigmented bands in nail of patient with dark skin
Sample new patient registration form.
Tumor marker analysis of a patient undergoing therapy, who (1) after surgery had residual disease ...